Figure 1.
Overview of immune responses to viral vectors. Targeting specific organs, engineering viral envelopes, switching serotypes, modifying the transgene cassette, utilizing tissue-specific promoters, or immune modulation regimens can result in immune avoidance to the viral vector and transgene product, and in some cases even induce tolerance to the therapeutic gene product.
